Seeking Alpha

Brian Nichols

 
(In beta) Send Us Feedback»
Title Symbol Long/
Short
Date of
publication
3m from
publication
6m from
publication
1y from
publication
Walgreen Might Be Our Best Shot At A Lower Tax Rate WAG Long
8/19/2014
9.6%
-
-
Facebook Vs. Its Peers: The Old Standard In New Tech FB Long
3/25/2014
3.9%
19.0%
-
Celldex Therapeutics Is Shutting Down CDX-1135: What Does It Mean? CLDX Long
3/10/2014
-30.7%
-37.3%
-
Zeiher Study Likely Predicts The Outcome Of NeoStem's AMR-001 Trial NBS Long
3/10/2014
-1.2%
-23.4%
-
Is OncoSec Medical Set To Trade Even Higher? ONCS Long
3/10/2014
-23.0%
-39.1%
-
Has Alexion's Stock Gotten Ahead Of Itself? ALXN Short
2/19/2014
-12.2%
-5.9%
-
XPO Logistics: Should Investors Buy So Soon After Its Large Offering? XPO Long
2/9/2014
-11.4%
14.6%
-
6 Reasons Why Bristol-Myers Is A Good Immuno-Oncology Investment For 2014 BMY Long
1/31/2014
0.9%
2.8%
-
OncoSec Executives Talk Electroporation, PD-1 Checkpoint Inhibitors, And The Unmet Need In Immune-Oncology ONCS Long
1/29/2014
55.3%
0.0%
-
Could PCT Be NeoStem's Breakout Star? NBS Long
1/27/2014
-6.6%
-11.0%
-
Will Galena's Post-Holiday Charm Continue? GALE Long
12/19/2013
-24.1%
-25.4%
-
Why Is Complete Enrollment Important To NeoStem Investors? NBS Long
12/17/2013
24.1%
15.0%
-
Is 'Apples To Oranges' Really The Best Biotechnology Investment Strategy? NBS Long
12/2/2013
11.3%
7.2%
-
Should Johnson & Johnson Bet On An Antipsychotic Acquisition? JNJ Long
11/18/2013
-1.6%
8.2%
18.7%
This Short-Term Pain Might Be Best For Long-Term Gain NBS Long
10/15/2013
-2.4%
-8.1%
-24.9%
Pimavanserin: The Most Underestimated Blockbuster In Biotechnology ACAD Long
10/14/2013
3.4%
-24.2%
-2.7%
NeoStem: An Investment In 4 Different Divisions NBS Long
9/30/2013
-19.5%
-18.5%
-35.3%
NeoStem Continues To Soar Behind A Slew Of Key Developments NBS Long
9/16/2013
-26.4%
-9.4%
-35.3%
Is The Price Right For This Biotech Favorite? REGN Long
8/16/2013
21.2%
40.3%
50.9%
Galena Biopharma: Best And Worst Case Scenario GALE Long
8/14/2013
44.0%
86.5%
31.0%
Great Leadership And Massive Opportunities Makes This Hire Terrific NBS Long
7/30/2013
-13.9%
3.8%
-13.2%
Barron's Makes Another Premature Call: Round 2 - Restoration Hardware RH Long
7/30/2013
7.5%
-15.1%
26.4%
NeoStem - Great Reverse-Split Activity, But What's Next? NBS Long
7/25/2013
-7.4%
0.7%
-15.4%
What Can You Learn From Acadia Pharmaceuticals' Exceptional Year? ACAD Long
7/24/2013
30.2%
21.7%
9.7%
What Does This Reverse Split Mean For NeoStem Shareholders? NBS Long
7/12/2013
31.7%
34.7%
13.4%
Finally! Electroporation Is Being Noticed By The Street INO Long
7/11/2013
58.5%
103.1%
94.6%
A Small Unnoticed Stock That Deserves Your Due Diligence ENZ Long
5/27/2013
6.0%
4.7%
65.5%
The Vatican / NeoStem Partnership Looks To Create Interest And Advance Cell Therapy NBS Long
4/10/2013
-9.6%
3.4%
0.7%
Investing For Tomorrow, Not Today XPO Long
2/19/2013
-4.6%
18.8%
43.9%
A Look At ImmunoCellular Therapeutics Just Prior To Interim Data IMUC Long
2/12/2013
-4.7%
23.2%
-52.4%
Spectrum Pharmaceuticals: Here's One Acquisition Rumor That I Wouldn't Mind Chasing SPPI Long
2/5/2013
-41.4%
-32.0%
-36.8%
Could Google Really Buy Zillow (Or Trulia)? GOOG Long
1/24/2013
7.9%
19.8%
49.1%
What Makes For A Market Leading Return In Biotechnology? GALE Long
1/22/2013
28.2%
-2.2%
234.8%
A Recent History Lesson: How To Play The Dell Acquisition DELL Long
1/16/2013
12.0%
4.4%
12.9%
XPO Logistics: Hitting Goals And Preparing For Another Acquisition XPO Long
1/8/2013
-4.5%
11.4%
75.1%
2012 Breakthroughs In Cell Therapy Development NBS Long
1/7/2013
-3.1%
-18.6%
9.3%
Galena Pulls Back While Analysts Rush To Its Defense GALE Long
12/17/2012
2.7%
12.8%
113.9%
Sprint Nextel And Alcatel-Lucent: Assessing Deep Value And Upside In 2013 S Long
12/14/2012
5.6%
31.9%
51.9%
Acadia Pharmaceuticals And Galena Biopharma: What A Difference A Trial Design Can Make ACAD Long
11/28/2012
18.1%
180.0%
351.2%
NeoStem CEO Dr. Smith Talks PCT Potential And Explains Recent Bullish Developments NBS Long
11/5/2012
-0.6%
-14.2%
4.2%
Bradley Jacobs Talks XPO Logistics Growth, Outlook And Turbo: 'It's A Home Run' XPO Long
10/30/2012
21.7%
18.8%
53.8%
Watch For Short-Term Gains In Shares Of NeoStem NBS Long
10/3/2012
-11.9%
-8.3%
8.9%
Value Of The Week: Seagate Technology STX Long
9/26/2012
0.4%
18.6%
45.3%
Facebook Worth $15? Seems A Little Premature Considering The Value Of The Space FB Long
9/24/2012
29.5%
23.8%
133.0%
Is Mellanox The Next Travelzoo? MLNX Long
9/11/2012
-31.6%
-43.8%
-62.7%
Spectrum Pharmaceuticals: Raj Sets The Record Straight And Quiets The Naysayers SPPI Long
9/2/2012
-2.8%
-4.8%
-36.3%
ICT-107 Into Perspective: Part 2 IMUC Long
8/28/2012
-16.2%
0.4%
15.8%
ImmunoCellular CEO Steps Down But Leaves Company Well Positioned IMUC Long
8/20/2012
-23.5%
1.2%
13.2%
ICT-107 Into Perspective: Part 1 IMUC Long
8/15/2012
-44.9%
-15.0%
-4.7%
Spectrum Pharmaceuticals Falls Hard With No Logical Explanation SPPI Long
8/9/2012
-8.5%
3.5%
-34.9%
Cramer, Like Most, Has It All Wrong Regarding Sprint S Long
8/1/2012
29.9%
31.7%
47.7%
Costly Mistakes Crush Dendreon But Upside May Lurk DNDN Long
8/1/2012
-12.1%
35.8%
5.0%
XPO Logistics: Seeking A Reason For The Recent Loss XPO Long
7/27/2012
1.8%
27.9%
83.9%
ImmunoCellular Therapeutics: Explaining The Benefits Of A Multiple Antigen Targeting Approach IMUC Long
7/23/2012
-34.6%
-34.0%
-25.6%
NeoStem Continues To Rally Behind Its Key Developments NBS Long
7/17/2012
2.8%
-14.1%
-15.5%
Spectrum Pharmaceuticals Reached 10-Year Highs But Has At Least 20% Upside In The Immediate Future SPPI Long
7/3/2012
-24.4%
-23.2%
-49.5%
Sprint: Definitely Worth Watching Near $3 S Long
6/13/2012
76.9%
91.8%
149.0%
ImmunoCellular Therapeutics' Uplisting To NYSE Could Immediately Open Many Doors IMUC Long
5/29/2012
-23.2%
-34.6%
-21.7%
A Short Interview With Galena CEO Dr. Ahn To Address Recent Concerns GALE Long
5/25/2012
23.7%
28.2%
95.4%
NeuVax Developer Dr. Peoples Eliminates Speculation For Facts GALE Long
5/24/2012
23.7%
28.2%
95.4%
Dr. Robin Smith Explaining NeoStem: A True Value Play NBS Long
5/18/2012
83.1%
85.9%
66.2%
Neostem: Trio Of Catalysts? NBS Long
5/14/2012
84.7%
81.9%
62.5%
Pre-ASCO Interview With ImmunoCellular Therapeutics CEO Dr. Singh IMUC Long
5/10/2012
21.4%
-29.8%
-4.0%
Interviewing Mark Ahn: The Truth Behind NeuVax GALE Long
5/2/2012
12.4%
63.5%
77.4%
ImmunoCellular Therapeutics And The Benefits Of A Large Exchange IMUC Long
4/30/2012
22.3%
-29.2%
-3.1%
Mark Ahn Interview: NeuVax Demonstrated Preclinical And Clinical Benefit In All Levels Of HER2 Expression GALE Long
4/25/2012
36.1%
51.1%
85.7%
Successfully Profiting From Developmental Biotech IMUC Long
4/16/2012
23.7%
-8.5%
-8.5%
ImmunoCellular Therapeutics' Patent Acquisition Paradigm Shift IMUC Long
3/22/2012
18.8%
-0.6%
-14.0%
Galena Biopharma Preparing For A 3-Day Rally? GALE Long
3/21/2012
-45.1%
-34.7%
-30.7%
Galena Biopharma's Patent Creates Both Immediate And Long-Term Upside GALE Long
3/21/2012
-45.1%
-34.7%
-30.7%
Apple Can Reach $1,000 By 2013 AAPL Long
3/20/2012
-3.3%
15.8%
-24.3%
Coffee Holding Co. Chart Suggests Immediate Upside JVA Long
3/14/2012
-56.9%
-43.1%
-45.5%
JVA Investors Looking For $30 After Strong Earnings JVA Long
3/12/2012
-43.2%
-31.8%
-41.8%
Alcatel-Lucent: Recent Bernstein Downgrade Tells You To Buy ALU Long
3/2/2012
-37.8%
-52.6%
-40.9%
Alcatel-Lucent Quietly Trading Higher - And It's Just Getting Started ALU Long
2/20/2012
-44.1%
-53.4%
-40.9%
Comparing Fundamentals: Alcatel-Lucent Vs. Cisco ALU Long
2/13/2012
-31.3%
-46.4%
-26.1%
Interviewing Alan Mulally: Technology, Fuel And Growth F Long
2/3/2012
-14.3%
-28.3%
4.1%
Don't Sell Yet, Sprint May Surprise You S Long
2/2/2012
16.3%
94.1%
157.5%
Spectrum Pharma's Loss Is A Great Opportunity SPPI Long
1/26/2012
-24.8%
13.5%
-14.6%
How To Trade Sirius For Big Time Profits SIRI Long
1/19/2012
3.8%
-2.4%
49.1%
Why I'm Long Church & Dwight Instead Of P&G CHD Long
1/9/2012
8.9%
25.1%
23.7%
Nokia To Trend Higher In The Coming Days NOK Long
12/14/2011
1.7%
-47.9%
-15.3%
Pacific Ethanol: More Than Just A One Pop Stock PEIX Long
11/24/2011
10.3%
-40.5%
-75.6%
Royale Energy Set To Post Large Gains In Coming Days (Along With 7 Other Energy Stocks) ROYL Long
11/23/2011
37.8%
-24.6%
-14.8%
XPO Logistics: Eyeing A Huge Return Over The Next Few Years XPO Long
11/18/2011
54.4%
67.7%
48.6%
General Motors To Reverse Illogical Trend In The Near Future GM Long
11/10/2011
12.4%
-1.4%
10.3%
XPO Logistics' Gains Just Getting Started As Acquisitions Begin XPO Long
10/27/2011
-6.8%
36.5%
8.0%
A Bullish Case For Travelzoo TZOO Long
10/4/2011
3.1%
-14.2%
-5.8%
How Eli Lilly Will Outwit Patent Expirations LLY Long
9/26/2011
15.2%
12.8%
35.3%
A Bullish Case For MGM MGM Long
9/26/2011
-6.4%
36.7%
-0.9%
A Bullish Case For Corning Incorporated GLW Long
9/25/2011
8.9%
14.7%
7.2%
Find Serious Upside In Regions Financial RF Long
9/21/2011
23.7%
93.4%
121.3%
A Bullish Stance On Alcatel-Lucent ALU Long
9/15/2011
-54.5%
-27.3%
-61.8%
A Bullish Case For Sirius XM SIRI Long
9/15/2011
-3.3%
23.8%
34.3%
How Google's Latest Acquisition Will Affect OpenTable And Travelzoo GOOG Long
9/9/2011
19.5%
14.4%
34.5%
Acura: A Play on the Cost of Substance Abuse ACUR Long
7/21/2011
51.4%
21.8%
-4.3%
Citigroup Should See Accelerated Growth in the Coming Months C Long
7/21/2011
-24.8%
-26.4%
-35.8%
Nokia: This Stock May Surprise You. Here's Why NOK Long
7/20/2011
12.3%
-3.2%
-68.1%
Bradley Jacobs and Express-1: The Billion Dollar Man and His New Project XPO Long
7/19/2011
-34.2%
-18.9%
5.4%